MedPath

BUCK INSTITUTE FOR RESEARCH ON AGING

BUCK INSTITUTE FOR RESEARCH ON AGING logo
🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.buckinstitute.org

Clinical Trials

5

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Temporal Investigation of Multimodal Elements

Recruiting
Conditions
Health
First Posted Date
2025-08-06
Last Posted Date
2025-08-15
Lead Sponsor
Buck Institute for Research on Aging
Target Recruit Count
120
Registration Number
NCT07107386
Locations
🇺🇸

Buck Institute, Novato, California, United States

GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women

Not Applicable
Recruiting
Conditions
Postmenopause
Metabolism
Geroscience
First Posted Date
2025-02-06
Last Posted Date
2025-07-18
Lead Sponsor
Buck Institute for Research on Aging
Target Recruit Count
30
Registration Number
NCT06813261
Locations
🇺🇸

The Buck Institute for Research on Aging, Novato, California, United States

Targeting Aging With a Ketone Ester for Function in Frailty

Not Applicable
Recruiting
Conditions
Frail Elderly
Aging
Immune Function
Muscle Function
First Posted Date
2024-10-17
Last Posted Date
2025-08-15
Lead Sponsor
Buck Institute for Research on Aging
Target Recruit Count
180
Registration Number
NCT06645847
Locations
🇺🇸

Buck Institute for Research on Aging, Novato, California, United States

🇺🇸

UConn Health, Farmington, Connecticut, United States

🇺🇸

Ohio State University, Columbus, Ohio, United States

Molecular Optimization Via Exercise (MOVE)

Recruiting
Conditions
Aging
First Posted Date
2024-08-06
Last Posted Date
2024-10-08
Lead Sponsor
Buck Institute for Research on Aging
Target Recruit Count
80
Registration Number
NCT06540287
Locations
🇺🇸

Buck Institute for Research on Aging, Novato, California, United States

Buck Institute Ketone Ester RCT

Not Applicable
Completed
Conditions
Safety Issues
Tolerance
Aging
First Posted Date
2022-10-19
Last Posted Date
2024-06-11
Lead Sponsor
Buck Institute for Research on Aging
Target Recruit Count
30
Registration Number
NCT05585762
Locations
🇺🇸

Buck Institute for Research on Aging, Novato, California, United States

News

Therapeutic Plasma Exchange Combined with Immunoglobulin Reduces Biological Age by 2.6 Years in Clinical Trial

A first-of-its-kind clinical trial demonstrates that therapeutic plasma exchange combined with intravenous immunoglobulin reduced biological age by an average of 2.61 years as measured by multi-omic biomarkers.

Metformin's Potential in Slowing Aging to be Examined in TAME Trial

The TAME Trial will investigate metformin's potential to prevent age-related diseases like heart disease, cancer, and cognitive decline in healthy older adults.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.